Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 201.e9-201.e18

  Lebedeva, Elena ^a   Stingl, Julia C ^a   Thal, Dietmar R ^a   Ghebremedhin, Estifanos ^a,b   Strauss, Joachim ^a   Özer, Esra ^a   Bertram, Lars ^c   von Einem, Björn ^a   Tumani, Hayrettin ^a   Otto, Markus ^a   Riepe, Matthias W ^a   Högel, Josef ^a   Ludolph, Albert C ^a   von Arnim, Christine A F ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cerebrospinal fluid; Haplotype; Presenilin2; amyloid 42

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; PRESENILIN 2;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81355139586     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.07.017     Document Type: Article

References (44)

1. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol 1999, 56:673-680.
2. Belbin O., Beaumont H., Warden D., Smith A.D., Kalsheker N., Morgan K. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients. Neurobiol. Aging 2008, 30:1992-1999.
3. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007, 39(1):17-23.
4. Bird T.D., Levy-Lahad E., Poorkaj P., Sharma V., Nemens E., Lahad A., Lampe T.H., Schellenberg G.D. Wide range in age of onset for chromosome 1 - related familial Alzheimer's disease. Ann. Neurol 1996, 40:932-936.
5. Blennow K., Vanmechelen E., Hampel H. CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol. Neurobiol 2001, 24:87-97.
6. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 1996, 17:1005-1013.
7. Brettschneider J., Petzold A., Schottle D., Claus A., Riepe M., Tumani H. The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease. Dement. Geriatr. Cogn. Disord 2006, 21:291-295.
8. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med 1997, 3:67-72.
9. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998, 391:387-390.
10. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-Tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713.
11. Fagan A.M., Roe C.M., Xiong C., Mintun M.A., Morris J.C., Holtzman D.M. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol 2007, 64:343-349.
12. Fagan T., Kagan B., Corbin D., Hwang W., Glabe C., Nault L., Lal R., Teplow D., Albensi B., Sokolov Y. Alzheimer Research Forum Live Discussion: Now you see them, now you don't: The amyloid channel hypothesis. J. Alzheimers Dis 2006, 9:219-224.
13. Galasko D., Chang L., Motter R., Clark C.M., Kaye J., Knopman D., Thomas R., Kholodenko D., Schenk D., Lieberburg I., Miller B., Green R., Basherad R., Kertiles L., Boss M.A., Seubert P. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch. Neurol 1998, 55:937-945.
14. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
15. Gustafson D.R., Skoog I., Rosengren L., Zetterberg H., Blennow K. Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women. J. Neurol. Neurosurg. Psychiatry 2007, 78:461-464.
16. Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., Umans L., Schrijvers V., Checler F., Vanderstichele H., Baekelandt V., Dressel R., Cupers P., Huylebroeck D., Zwijsen A., Van Leuven F., De Strooper B. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11872-11877.
17. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H.C., Riemenschneider M., De Deyn P.P., Bancher C., Cras P., Wiltfang J., Mehta P.D., Iqbal K., Pottel H., Vanmechelen E., Vanderstichele H. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 1999, 52:1555-1562.
18. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42 (43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42 (43). Neuron 1994, 13:45-53.
19. Lewczuk P., Esselmann H., Otto M., Maler J.M., Henkel A.W., Henkel M.K., Eikenberg O., Antz C., Krause W.R., Reulbach U., Kornhuber J., Wiltfang J. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau. Neurobiol. Aging 2004, 25:273-281.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
21. Nikisch G., Wiedemann G., Kiessling B., Hertel A. Familial Alzheimer's disease with presenilin 2 N14 1I mutation. A case report. Fortschr. Neurol. Psychiatr 2008, 76:606-609.
22. Otto M., Lewczuk P., Wiltfang J. Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. Methods 2008, 44:289-298.
23. Palacino J.J., Berechid B.E., Alexander P., Eckman C., Younkin S., Nye J.S., Wolozin B. Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cells. J Biol Chem 2000, 275:215-222.
24. Pastor P., Roe C.M., Villegas A., Bedoya G., Chakraverty S., Garcia G., Tirado V., Norton J., Rios S., Martinez M., Kosik K.S., Lopera F., Goate A.M. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E2 80A PS1 kindred. Ann. Neurol 2003, 54:163-169.
25. Portelius E., Andreasson U., Ringman J.M., Buerger K., Daborg J., Buchhave P., Hansson O., Harmsen A., Gustavsson M.K., Hanse E., Galasko D., Hampel H., Blennow K., Zetterberg H. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol. Neurodegener 2010, 5:2.
26. Prince J.A., Zetterberg H., Andreasen N., Marcusson J., Blennow K. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 2004, 62:2116-2118.
27. Schöttle D. Differentiation of dementias through combination of different parameters in cerebrospinal fluid [german]. Dissertation, Universität Ulm, Medizinische Fakultät http://vts.uni-ulm.de/doc.asp?id=6671.
28. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol 1994, 10:373-403.
29. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997, 89:629-639.
30. Sjogren M., Gisslen M., Vanmechelen E., Blennow K. Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci. Lett 2001, 314:33-36.
31. Skoog I., Davidsson P., Aevarsson O., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Dement. Geriatr. Cogn. Disord 2003, 15:169-176.
32. Sloan C.D., Shen L., West J.D., Wishart H.A., Flashman L.A., Rabin L.A., Santulli R.B., Guerin S.J., Rhodes C.H., Tsongalis G.J., McAllister T.W., Ahles T.A., Lee S.L., Moore J.H., Saykin A.J. Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes. Am. J. Med. Genet. B Neuropsychiatr. Genet 2010, 153B:1060-1069.
33. St George-Hyslop P.H. Piecing together Alzheimers. Sci. Am 2000, 283:76-83.
34. Stomrud E., Hansson O., Blennow K., Minthon L., Londos E. Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Dement. Geriatr. Cogn. Disord 2007, 24:118-124.
35. Sunderland T., Mirza N., Putnam K.T., Linker G., Bhupali D., Durham R., Soares H., Kimmel L., Friedman D., Bergeson J., Csako G., Levy J.A., Bartko J.J., Cohen R.M. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol. Psychiatry 2004, 56:670-676.
36. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., Obata K. The presenilin 2 mutation (N14 1I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2025-2030.
37. Uttner I., Kirchheiner J., Tumani H., Mottaghy F.M., Lebedeva E., Ozer E., Ludolph A.C., Huber R., von Arnim C.A. A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF. Eur., J Neurourol 2010, 17:631-633.
38. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991, 337:1158-1159.
39. Wiltfang J., Esselmann H., Smirnov A., Bibl M., Cepek L., Steinacker P., Mollenhauer B., Buerger K., Hampel H., Paul S., Neumann M., Maler M., Zerr I., Kornhuber J., Kretzschmar H.A., Poser S., Otto M. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann. Neurol 2003, 54:263-267.
40. Wiltfang J., Lewczuk P., Riederer P., Grunblatt E., Hock C., Scheltens P., Hampel H., Vanderstichele H., Iqbal K., Galasko D., Lannfelt L., Otto M., Esselmann H., Henkel A.W., Kornhuber J., Blennow K. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psychiatry 2005, 6:69-84.
41. Wimo A., Winblad B., Aguero-Torres H., von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis. Assoc. Disord 2003, 17:63-67.
42. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999, 398:513-517.
43. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M.B., Teplow D.B., Haass C., Seubert P., Koo E.H., Selkoe D.J. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem 1997, 272:7977-7982.
44. Zhang J., Chen J., Xu Q., Shen Y. Does the presenilin 2 gene predispose to schizophrenia?. Schizophr. Res 2009, 109:121-129.